Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas

Purpose. Patients with soft tissue sarcoma (STS) who have previously received standard chemotherapy including adriamycin (doxorubicin), ifosfamide, cyclophosphamide and DTIC (dacarbazine) have very limited therapeutic options. It is important to identify new drugs with some activity in this disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shreyaskumar R., Linke, Kaye A., Burgess, M. Andrew, Papadopoulos, Nicholas E., Plager, Carl, Jenkins, Jan, Benjamin, Robert
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395357/
https://www.ncbi.nlm.nih.gov/pubmed/18521208
http://dx.doi.org/10.1080/13577149778362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395357/
https://www.ncbi.nlm.nih.gov/pubmed/18521208
http://dx.doi.org/10.1080/13577149778362

Ejemplares similares